Trading Made Easy -- Check out our PRO Tool Set -- We highly recommend you check out GetStockIdeas.com for great tools to enhance your trading!

ARCA biopharma, Inc.
(NASDAQ : ABIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading ABIO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.58%72.421.2%$702.73m
CELGCelgene Corporation
-1.04%117.631.3%$671.11m
AMGNAmgen Inc.
1.14%144.011.0%$653.64m
BIIBBiogen Inc.
0.48%297.191.2%$540.76m
REGNRegeneron Pharmaceuticals, Inc.
-0.76%372.713.6%$428.37m
ALXNAlexion Pharmaceuticals, Inc.
0.78%122.961.9%$413.92m
ILMNIllumina, Inc.
0.14%127.903.0%$185.91m
VRTXVertex Pharmaceuticals Incorporated
-2.98%75.502.9%$164.07m
TSROTESARO, Inc.
1.99%133.3617.1%$161.54m
INCYIncyte Corporation
2.09%102.022.4%$157.65m
IONSIonis Pharmaceuticals, Inc.
4.04%43.0010.0%$142.34m
EXELExelixis, Inc.
5.15%17.376.4%$127.65m
BLUEBluebird Bio, Inc.
1.60%69.7523.3%$124.58m
BMRNBioMarin Pharmaceutical Inc.
-1.34%82.214.5%$117.15m
SGENSeattle Genetics, Inc.
-0.02%66.708.7%$112.48m

Company Profile

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. ARCA biopharma was founded in 1992 and is headquartered in Westminster, CO.